CLINICAL_TRIALS
trial_result
· 2018-06-11
Clinical Trial Update: Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus [Phase 2]
Summary
Phase 2 dose-ranging trial of Adcetris (brentuximab vedotin) in adults with systemic lupus erythematosus was terminated; results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seagen Inc. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2018-06-11